Intellimedix

About:

Intellimedix develops innovative approaches to accelerate the discovery and development of new treatments for known human diseases.

Website: http://intellimedix.com/

Top Investors: Christopher Klaus

Description:

Intellimedix develops innovative approaches to accelerate the discovery and development of new treatments for known human diseases. The company, headquartered in Atlanta, GA with a research laboratory in Cambridge, MA, is guided by the principle of open innovation. Intellimedix works closely with patients and their doctors, non-profits, and academic institutions in order to promote the free flow of knowledge and information for the benefit of all. Intellimedix has teamed up with world-class experts in the fields of systems biology, computer science, neuroscience, and biological engineering.

Total Funding Amount:

$2.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Atlanta, Georgia, United States

Founded Date:

2012-01-01

Contact Email:

contact(AT)intellimedix.com

Founders:

Brian Litt, Daniel Fischer, Jim Jacoby

Number of Employees:

11-50

Last Funding Date:

2015-02-23

IPO Status:

Private

Industries:

© 2025 bioDAO.ai